Authors: Elizabeth Wager, Rahul Mhaskar, Stephanie Warburton, Benjamin Djulbegovic
DOI: 10.1371/journal.pone.0013591
Abstract Summary
JAMA’s 2005 policy requiring independent statistical analysis for industry-funded trials led to a significant drop in published industry-sponsored studies, while competitor journals saw increases. This suggests the policy deterred submissions or reduced acceptance rates, raising questions about balancing editorial rigor with access to industry research.
Why Brain? ðŸ§
JAMA’s 2005 policy requiring independent statistical analysis for industry-funded trials led to fewer such studies being published, suggesting pharmaceutical companies may avoid journals with stricter oversight requirements.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.